The role of chemotherapy in the treatment of head and neck cancer.
Inuyama
Y
Y
Department of Otolaryngology, Hokkaido University School of Medicine.
Fukuda
S
S
Furuta
Y
Y
Yagi
K
K
Nagahashi
T
T
Chida
E
E
Shirato
H
H
Fujii
M
M
Kanzaki
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000188:drug therapy / Q000401:mortality; D017663:Peplomycin / Q000008:administration & dosage; D015996:Survival Rate; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D004338:Drug Combinations; C096910:UFT(R) drug; D005641:Tegafur; D017663:Peplomycin; D014498:Uracil; D016190:Carboplatin; D002945:Cisplatin